Relmada Therapeutics
RLMD
#9903
Rank
A$18.37 M
Marketcap
$0.61
Share price
4.60%
Change (1 day)
-87.38%
Change (1 year)

Relmada Therapeutics (RLMD) - Cash on Hand

Cash on Hand as of September 2024 : A$86.79 Million

According to Relmada Therapeutics's latest financial reports the company has A$86.79 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Relmada Therapeutics - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$0.21 B-25.43%
2021-12-31A$0.29 B91.95%
2020-12-31A$0.15 B
2019-06-30A$13.12 M333.99%
2018-06-30A$3.02 M35.88%
2017-06-30A$2.22 M-80.44%
2016-06-30A$11.37 M-61.14%
2015-06-30A$29.28 M7.88%
2014-06-30A$27.14 M
2013-08-31A$0.01 M97.32%
2012-08-31A$0 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.44 B 1,567.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$1.62 B 1,769.43%๐Ÿ‡บ๐Ÿ‡ธ USA